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G03 Rehabilitation Medicine
(472) Does rehabilitation dose predict functional recovery after
total knee replacement?
J Lee, B Rakel, T Johnston,W Angstrom, N Logsden-Sackett, Y Perkhounkova,
X Yang, C Clark, N Noiseux, J Callaghan, and K Sluka; University of Iowa, Iowa
City, IA
Total knee replacement (TKR) is a cost-effective treatment, with benefits of im-
proved pain, function and quality of life. Considerable rehabilitation is needed
to maximize recovery speed post-TKR, yet how rehabilitation dose influences
functional recovery is not well-understood. The aim of this study was to deter-
minewhether exercise dose or general activity predict functional improvement
6weeks following TKR. On postoperative day 2 (POD2) and at 6weeks, 151 par-
ticipants (61.369.6yrs) completed 4 knee function tasks (extension, extensor
lag, flexion, walking speed), and rated their pain on a 21-point numeric scale.
They also completed home record logs for 6 weeks, including daily minutes of
(1)exercise dose (physical therapy, home exercises), and (2)other activity
(housework, gardening), and pain with each task. Prescribed exercise was sig-
nificantly higher in weeks 1 and 2 (45.7619.2), and 3 and 4 (46.8621.9) com-
pared to 5 and 6 (38.9620.8)(Wilcoxon test, p’s < .001). Function improved
significantly for all tasks from POD2 to 6 weeks (p’s < .001). Walking speed im-
provement was positively associated with prescribed rehabilitation dose dur-
ing weeks 3 and 4 (multiple regression; b = 4.48, p < .01). Exercise dose was
not associatedwith function change for the other tasks. A POD2walking speed
by sex interaction was observed for walking speed (b = -0.82, p = .01): males
with lower POD2 speeds had greater improvements than males with higher
POD2 speeds. Pain at 6 weeks was associated with less improvement for all
tasks, and age was associated with poorer walking speed and flexion change-
s(p’s > .01). These results suggest exercise dose translates to better functional
improvement, and people with higher pain and who are older have poorer
functional recovery. Our study is the first to examine whether physical rehabil-
itation dose affects functional recovery after TKR and shows that dose is impor-
tant for improvement in function. Funding: NINR R01 NR009844.
(473) Corticomotor excitability during a noxious stimulus and
following exercise in women with fibromyalgia
M Bement, A Weyer, T Yoon, and S Hunter; Marquette University, Milwaukee,
WI
In young healthy adults, application of a noxious stimulus increases corticomo-
tor excitability (motor evoked potentials, MEP) to the contralateral limb. Imme-
diately following a sustained isometric contraction, the pain-induced increase
in corticomotor excitability decreases in parallel with a decrease in pain re-
ports. The purpose of this study was to assess corticomotor excitability during
a noxious stimulus before and after isometric exercise in women with fibro-
myalgia. Fifteen women with fibromyalgia (53.769.9 years) participated in
three research sessions: one familiarization and two randomized experimental.
The experimental sessions involved measurement of pain perception and mo-
tor evoked potentials (MEPS) of the biceps brachii before and after 1) 30 min-
utes of quiet rest or 2) a fatiguing submaximal isometric contraction with the
elbow flexor muscles. Corticomotor excitability was quantified as the ampli-
tude of theMEP evoked at rest in the elbowflexormuscles in response to trans-
cranial magnetic stimulation. Pain perception, measured as pain threshold and
pain ratings, was assessed with a custom-made pressure pain device placed on
the contralateral index finger for two minutes. Pain ratings were recorded ev-
ery 20 seconds using a 0-10 numerical rating scale. In contrast to healthy sub-
jects, women with fibromyalgia did not experience a pain-induced increase
in corticomotor excitability (p>0.05). Furthermore, following the submaximal
isometric contraction, there was no change in pain reports or MEP amplitude
compared with the quiet rest session (p>0.05). Thus, corticomotor excitability
during a noxious stimulus and following exercise is very different for women
with fibromyalgia compared with healthy adults. Supported by a grant from
the Arthritis Foundation.
(474) Wearable long-duration ultrasound treatment of chronic
trapezius myalgia
G Lewis, S Guarino, and R Ortiz; Cayuga Medical Center, Ithaca, NY
Recent research suggests that Traditional ultrasound therapy (TUS) is most clin-
ically effective on pain treatment when administered daily. However, owing to
the patient costs and inconvenience of regular TUS, it is not considered a self-
pain management approach to pain therapy. The purpose of this study was to
evaluate if a novel wearable low intensity therapeutic ultrasound (LITUS) de-
vice could reduce patient’s pain, be easily self-applied at home, and if daily
LITUS had an overall therapeutic benefit to treating chronic trapezius myalgia.
The wearable LITUS device is about the size of an iPod and provides 5 to 6
hours of 2.75 MHz ultrasound therapy at 90mW/cm2 on a single charge. The
wide-beam device treats a softball size volume and is attached to the body
with ultrasound gel and tegaderm bandage. The LITUS device was evaluated
in a double-blinded placebo-controlled study under CayugaMedical Center In-
stitutional Review Board approval. The patient population consisted of 30 sub-
jects, 40-60 years of age, with starting daily-pain ratings of <7 on the visual
analog scale (VAS), and medically diagnosed with chronic trapezius myalgia.
Each subject logged a daily 1 hour treatment session for 10-12 consecutive
days at the onset of trapezius spasm, and recorded VAS and GROC scores in
their user diary. On average subjects reported a 2x VAS pain reduction over pla-
cebo. Placebo users had a 6.54% pain reduction, female and male active users
had a 11.76% and 15.02%pain reduction, respectively. For the GROC, the aver-
age improvement over placebo was 3x. Placebo users had a 12.75% improve-
ment, female and male active users had a 28.68% and 47.98% improvement,
respectively. In almost all treatment sessions, the wearable LITUS device pro-
vided improved pain reduction over placebo, and no adverse events were re-
ported during or after the study.
(475) High intensity TENS reduces pain during dressing
changes on open wounds: a proof of concept study
L Malloy, E Borhart, S Gardner, N Petsas, N Logsden-Sackett, and B Rakel;
University of Iowa, Iowa City, IA
Dressing changes on openwounds causemoderate to severe pain in 50-80%of
patients, which interferes with wound care. Effective interventions without
significant side effects are lacking to control this procedure-evoked wound
pain. The effect of high intensity transcutaneous electrical nerve stimulation
(HI-TENS) for reducing procedure-evokedwound pain during dressing changes
on open wounds was examined using a pre-post pilot study of 24 subjects. In-
patients reporting a pain intensity$ 4 on a 0-10 NRS during a screening dress-
ing change of both acute and chronic open wounds were enrolled. Subjects’
were primarily female (62.5%) and had a mean age of 49.3 6 13.9 years. HI-
TENS was applied 20 minutes prior to the intervention dressing change using
four electrodes placed the top and bottom of both sides of the wound dressing
at points of least resistance. Subjects controlled increases in amplitude to pro-
mote acceptance of sensation resulting in amean amplitude of 48.66 10.6mA.
Four of the 24 subjects received preventive or procedural analgesia during the
HI-TENS dressing change beyond what they received during their screening
dressing change so were eliminated from the analyses. The mean reduction
in pain intensity with HI-TENS for the remaining 20 subjects was 2.3, going
from an average pain intensity of 7.05 6 1.97 without HI-TENS to 4.7 6 2.55
with HI-TENS. This effect is similar in magnitude to that demonstrated with
pharmacologic strategies for this purpose and HI-TENS far fewer side effects
than opioids, such as sedation and nociceptor sensitization. Therefore, HI-
TENS represents a preventive intervention for procedure-evoked wound pain
that deserves further study in a large randomized clinical trial. If HI-TENS is
shown to be effective, the positive impact would be improved wound out-
comes because reduced procedure-evoked pain will lead to more thorough
wound care, decreased infection, and better wound healing.
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